Abstract
Background
Patients diagnosed with stage II and III esophageal squamous cell carcinoma (ESCC) have variable prognosis. This group would benefit greatly from the discovery of prognostic markers that are capable of identifying individuals for whom adjuvant treatment would be advantageous. The aim of this study was to investigate the impact of immunohistochemically detected cytokeratin 7 (CK7) expression on disease-free survival, overall survival (OS), or therapeutic outcome in patients with ESCC.
Methods
Immunohistochemical analysis of CK7 was performed on 225 surgically resected specimens of stage 0–III ESCC.
Results
In total, 20 (9%) of 225 ESCC cases were positive for CK7. In stage 0–III ESCC patients, CK7 expression was statistically significantly associated with OS, independent of clinical covariates, including tumor, node, metastasis system stage. In stage II and III ESCC patients (n = 124), CK7 expression was significantly associated with poorer OS (P = 0.0377). Furthermore, in stage II and III ESCC patients who did not receive adjuvant chemotherapy (n = 73), CK7 expression was significantly associated with poorer OS (P = 0.0003). CK7 expression was not associated with therapeutic outcome in patients with stage II and III ESCC who received adjuvant chemotherapy. In patients with CK7-positive ESCC (n = 16), receipt of adjuvant chemotherapy tended to be beneficial for patients with stage II and III ESCC (P = 0.0654).
Conclusions
Immunohistochemical analysis of CK7 will help to identify high-risk patients.
Similar content being viewed by others
References
IARC 2003 Oesophageal cancer. In: Stewart BW, Kleihues P (eds) World cancer report. Lyon: IARC Press, pp. 223–7.
Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer. 1992;69:1088–93.
Courrech Staal EF, van Coevorden F, Cats A, Aleman BM, van Velthuysen ML, Boot H et al. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center. Ann Surg Oncol. 2009;16:3219–26.
Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874–81.
Noguchi T, Oue N, Wada S, Sentani K, Sakamoto N, Kikuchi A et al. h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16:1390–6.
Isohata N, Aoyagi K, Mabuchi T, Daiko H, Fukaya M, Ohta H et al. Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer. 2009;125:1212–21.
Sakamoto N, Oue N, Noguchi T, Sentani, K., Anami, K., Sanada, Y, et al. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma. Cancer Sci. 2010;101:1038–44.
Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, et al. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol. 2010;36:321–30.
Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–33.
Yamada A, Sasaki H, Aoyagi K, Sano M, Fujii S, Daiko H, et al. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Oncol Rep. 2008;20:1021–7.
Sobin LH, Wittekind CH, editors. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002:60–4.
Haleem A, Kfoury H, Al Juboury M, Al Husseini H. Paget’s disease of the oesophagus associated with mucous gland carcinoma of the lower oesophagus. Histopathology. 2003;42:61–5.
Acknowledgment
We thank Shinichi Norimura for his technical assistance and advice. This work was carried out with the cooperation of the Research Center for Molecular Medicine of the Faculty of Medicine of Hiroshima University. We thank the Analysis Center of Life Science of Hiroshima University for the use of their facilities. This work was supported in part by grants-in-aid for Cancer Research from the Ministry of Education, Culture, Science, Sports and Technology of Japan and in part by a grant-in-aid for the Third Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, and by the National Institute of Biomedical Innovation (Program for Promotion of Fundamental Studies in Health Sciences) and by National Cancer Center Research and Development Fund.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Oue, N., Noguchi, T., Anami, K. et al. Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 19, 1902–1910 (2012). https://doi.org/10.1245/s10434-011-2175-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-011-2175-4